The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Epithelial-Mesenchymal Transition Induced by Senescent Fibroblasts
Open accessAbstract
Depending on the cell type and tissue environment, epithelial and mesenchymal cell phenotypes are not static and can be highly dynamic. Epithelial-mesenchymal transitions (EMTs) and reverse EMTs provide flexibility during embryogenesis. While EMTs are a critical normal process during development and wound healing, properties of the EMT have been implicated in human pathology, particularly cancer metastasis. A normal undamaged epithelium does not typically exhibit features of an EMT. However, particularly under the influence of the surrounding microenvironment, cancer cells may reactivate developmental phenotypes out of context in the adult. This reactivation, such as the EMT, can facilitate tumor cell invasion and metastasis, and therefore is a major mechanism of tumor progression. Conversely, cellular senescence, which is associated with aging, is a process by which cells enter a state of permanent cell cycle arrest, thereby constituting a potent tumor suppressive mechanism. However, accumulating evidence shows that senescent cells can have deleterious effects on the tissue microenvironment. The most significant of these effects is the acquisition of a senescence-associated secretory phenotype (SASP) that turns senescent fibroblasts into pro-inflammatory cells having the ability to promote tumor progression, in part by inducing an EMT in nearby epithelial cells. Here, we summarize the potential impacts of SASP factors, particularly interleukins, on tissue microenvironments and their ability to stimulate tumor progression through induction of an EMT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Senescent fibroblasts induce an epithelial-to-mesenchymal transition in premalignant epithelial cells and nonaggressive cancer epithelial cells in part through the secretion of IL-6 and IL-8 (32, 102, 118).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [102]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In addition to stimulating tumor growth in mice, SASP factors can stimulate malignant phenotypes in culture.”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [102]
The cited source says what the claim attributes to it.
In the citing paper
“One such phenotype is the epithelial-to-mesenchymal transition (102) (Figure 2).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [102]
The cited source says what the claim attributes to it.
In the citing paper
“The SASP can have a major impact on various biological processes, including cell proliferation, angiogenesis, inflammation16, epithelial-to-mesenchymal transition17, tissue repair18 and wound healing3 (Fig. 2).”
From Spatial mapping of cellular senescence: emerging challenges and opportunities (2023) · cites this paper as [17]
In the citing paper
“A known pathway for SASP-promoted cancer metastasis is the induction of epithelial to mesenchymal transition (EMT)”
From Redox control of senescence and age-related disease. (2017) · cites this paper as [106]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature reviews. Cancer · doi:10.1038/nrc822 · Cited by 6,767
The limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
Self-citationCellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Self-citationA DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917 · cited 1×
“damage signal that permanently arrests growth [15].”
Met, metastasis, motility and more
Birchmeier, C., Birchmeier, W., Gherardi, E., & Woude, G. F. V. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1261 · Cited by 2,652
Cited by
Sorted by citations
Oxidative stress, aging, and diseases
Liguori, I., Russo, G., Curcio, F., Bulli, G., Aran, L., Della-Morte, D., Gargiulo, G., Testa, G., Cacciatore, F., Bonaduce, D., et al. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s158513 · Cited by 3,979
Aging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954
Self-citationThe role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623
Kastenhuber, E. R., & Lowe, S. W. (2017) · Cell · doi:10.1016/j.cell.2017.08.028 · Cited by 1,906
Epithelial-Mesenchymal Transition in Cancer: A Historical Overview
Ribatti, D., Tamma, R., & Annese, T. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100773 · Cited by 1,051
Dash, U. C., Bhol, N. K., Swain, S. K., Samal, R. R., Nayak, P. K., Raina, V., Panda, S. K., Kerry, R. G., Duttaroy, A. K., & Jena, A. B. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.10.004 · Cited by 806
Fiaschi, T., Marini, A., Giannoni, E., Taddei, M. L., Gandellini, P., Donatis, A. D., Lanciotti, M., Serni, S., Cirri, P., & Chiarugi, P. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1949 · Cited by 598
Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression
Cirri, P., & Chiarugi, P. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9340-x · Cited by 529
Tumor and its microenvironment: A synergistic interplay
Catalano, V., Turdo, A., Franco, S. D., Dieli, F., Todaro, M., & Stassi, G. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.08.007 · Cited by 446
Monitoring Tumorigenesis and Senescence In Vivo with a p16INK4a-Luciferase Model
Burd, C. E., Sorrentino, J. A., Clark, K. S., Darr, D. B., Krishnamurthy, J., Deal, A. M., Bardeesy, N., Castrillon, D. H., Beach, D. H., & Sharpless, N. E. (2013) · Cell · doi:10.1016/j.cell.2012.12.010 · Cited by 419
SUMO and the robustness of cancer
Seeler, J.-S., & Dejean, A. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2016.143 · Cited by 443
Iannello, A., Thompson, T. W., Ardolino, M., Lowe, S. W., & Raulet, D. H. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130783 · Cited by 414
Zhu, X., Chen, Z., Shen, W., Huang, G., Sedivy, J. M., Wang, H., & Ju, Z. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00646-9 · Cited by 425
Redox control of senescence and age-related disease.
Chandrasekaran, A., Idelchik, M. D. P. S., & Melendez, J. A. (2017) · Redox Biology · doi:10.1016/j.redox.2016.11.005 · Cited by 360
Cell-to-cell communication: microRNAs as hormones.
Bayraktar, R., Van Roosbroeck, K., & Calin, G. A. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12144 · Cited by 361
Oxidative Stress, Tumor Microenvironment, and Metabolic Reprogramming: A Diabolic Liaison
Fiaschi, T., & Chiarugi, P. (2012) · International Journal of Cell Biology · doi:10.1155/2012/762825 · Cited by 321
Astrocyte senescence: Evidence and significance
Cohen, J., & Torres, C. (2019) · Aging Cell · doi:10.1111/acel.12937 · Cited by 281
Microenvironment and tumor cell plasticity: An easy way out
Taddei, M. L., Giannoni, E., Comito, G., & Chiarugi, P. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.01.042 · Cited by 272
Cell Senescence: Role in Aging and Age-Related Diseases
Campisi, J., & Robert, L. (2014) · Interdisciplinary Topics in Gerontology and Geriatrics · doi:10.1159/000358899 · Cited by 240
Self-citationZhu, Y., Liu, X., Ding, X., Wang, F., & Geng, X. (2019) · Biogerontology · doi:10.1007/s10522-018-9769-1 · Cited by 255
Glucocorticoids suppress selected components of the senescence‐associated secretory phenotype
Laberge, R., Zhou, L., Sarantos, M. R., Rodier, F., Freund, A., de Keizer, P. L. J., Liu, S., Demaria, M., Cong, Y., Kapahi, P., et al. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00818.x · Cited by 229
Self-citationEMT and Oxidative Stress: A Bidirectional Interplay Affecting Tumor Malignancy
Giannoni, E., Parri, M., & Chiarugi, P. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4280 · Cited by 234
Sonic Hedgehog Signaling in Organogenesis, Tumors, and Tumor Microenvironments
Jeng, K., Chang, C., & Lin, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030758 · Cited by 210
MicroRNAs linking inflamm-aging, cellular senescence and cancer
Olivieri, F., Rippo, M. R., Monsurrò, V., Salvioli, S., Capri, M., Procopio, A. D., & Franceschi, C. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.05.001 · Cited by 210
Cartilage regeneration and ageing: Targeting cellular plasticity in osteoarthritis
Varela-Eirín, M., Loureiro, J., Fonseca, E., Corrochano, S., Caeiro, J. R., Collado, M., & Mayán, M. D. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.12.006 · Cited by 206
SASP mediates chemoresistance and tumor-initiating-activity of mesothelioma cells
Canino, C., Mori, F., Cambria, A., Diamantini, A., Germoni, S., Alessandrini, G., Borsellino, G., Galati, R., Battistini, L., Blandino, R., et al. (2012) · Oncogene · doi:10.1038/onc.2011.485 · Cited by 200
Cieply, B. W., Farris, J. C., Denvir, J., Ford, H. L., & Frisch, S. M. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4082 · Cited by 193
Cellular senescence in cancer: from mechanisms to detection
Ou, H., Hoffmann, R. J., González‐López, C., Doherty, G. J., Korkola, J. E., & Muñoz‐Espín, D. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12807 · Cited by 208
Context-dependent effects of cellular senescence in cancer development.
Lecot, P., Alimirah, F., Desprez, P.-Y., Campisi, J., & Wiley, C. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.115 · Cited by 183
Self-citationThe pathogenesis of COPD and IPF: Distinct horns of the same devil?
Chilosi, M., Poletti, V. E., & Rossi, A. (2012) · Respiratory Research · doi:10.1186/1465-9921-13-3 · Cited by 187
A Novel Indication for Panobinostat as a Senolytic Drug in NSCLC and HNSCC
Samaraweera, L., Adomako, A., Rodriguez-Gabin, A., & McDaid, H. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-01964-1 · Cited by 183
Senescence as a therapeutic target in cancer and age-related diseases
McHugh, D., Durán, I., & Gil, J. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01074-4 · Cited by 197
Senescence Reprogramming by TIMP1 Deficiency Promotes Prostate Cancer Metastasis
Guccini, I., Revandkar, A., D'Ambrosio, M., Colucci, M., Pasquini, E., Mosole, S., Troiani, M., Brina, D., Sheibani-Tezerji, R., Elia, A. R., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2020.10.012 · Cited by 185
Obesity and type-2 diabetes as inducers of premature cellular senescence and ageing
Burton, D. G. A., & Faragher, R. (2018) · Biogerontology · doi:10.1007/s10522-018-9763-7 · Cited by 181
Senescence in Post-Mitotic Cells: A Driver of Aging?
von Zglinicki, T., Wan, T., & Miwa, S. (2021) · Antioxidants & Redox Signaling · doi:10.1089/ars.2020.8048 · Cited by 170
Chinta, S. J., Lieu, C. A., DeMaria, M., Laberge, R. ‐., Campisi, J., & Andersen, J. K. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12029 · Cited by 165
“SASP factors such as GROα, IL-6 and WNTs can enhance the proliferation of neoplastic epithelial cells [53, 57, 58], or promote epithelial–mesenchymal transition [54], which is a critical step in the development of metastatic cancer [59].”
Self-citationChambers, C. R., Ritchie, S., Pereira, B., & Timpson, P. (2021) · Molecular Oncology · doi:10.1002/1878-0261.13042 · Cited by 182
Perrott, K. M., Wiley, C. D., Desprez, P.-Y., & Campisi, J. (2017) · GeroScience · doi:10.1007/s11357-017-9970-1 · Cited by 163
Self-citationNrf2-Mediated Fibroblast Reprogramming Drives Cellular Senescence by Targeting the Matrisome
Hiebert, P., Wietecha, M. S., Cangkrama, M., Haertel, E., Mavrogonatou, E., Stumpe, M., Steenbock, H., Grossi, S., Beer, H., Angel, P. E., et al. (2018) · Developmental Cell · doi:10.1016/j.devcel.2018.06.012 · Cited by 172
The Senescence-Associated Secretory Phenotype: Critical Effector in Skin Cancer and Aging
Ghosh, K., & Capell, B. C. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.06.621 · Cited by 171
MLL1 is essential for the senescence-associated secretory phenotype
Capell, B. C., Drake, A. M., Zhu, J., Shah, P. P., Dou, Z., Dorsey, J., Simola, D. F., Donahue, G., Sammons, M., Rai, T. S., et al. (2016) · Genes & Development · doi:10.1101/gad.271882.115 · Cited by 156
Hwang, H. J., Lee, Y.-R., Kang, D., Lee, H., Seo, H. R., Ryu, J., Kim, Y.-N., Ko, Y., Park, H. J., & Lee, J. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.06.019 · Cited by 164
Chen, H., Chen, H., Liang, J., Gu, X., Zhou, J., Xie, C., Lv, X., Wang, R., Li, Q., Mao, Z., et al. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0371-7 · Cited by 149
Role of Hedgehog Signaling in Breast Cancer: Pathogenesis and Therapeutics
Galdo, N. A. R., Montero, Á. L., & Wertheimer, E. V. (2019) · Cells · doi:10.3390/cells8040375 · Cited by 145
Spatial mapping of cellular senescence: emerging challenges and opportunities
Gurkar, A. U., Gerencser, A. A., Mora, A. L., Nelson, A. C., Zhang, A. R., Lagnado, A. B., Enninful, A., Benz, C., Furman, D., Beaulieu, D., et al. (2023) · Nature Aging · doi:10.1038/s43587-023-00446-6 · Cited by 141
Conserved and novel functions of programmed cellular senescence during vertebrate development
Davaapil, H., Brockes, J. P., & Yun, M. H. (2016) · Development · doi:10.1242/dev.138222 · Cited by 124
Caveolin‐1, cancer and therapy resistance
Ketteler, J., & Klein, D. (2018) · International Journal of Cancer · doi:10.1002/ijc.31369 · Cited by 129
Senolytics for Cancer Therapy: Is All that Glitters Really Gold?
Carpenter, V. J., Saleh, T., & Gewirtz, D. A. (2021) · Cancers · doi:10.3390/cancers13040723 · Cited by 124
Extracellular Vesicles as New Players in Cellular Senescence
Urbanelli, L., Buratta, S., Sagini, K., Tancini, B., & Emiliani, C. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091408 · Cited by 126
Autophagy and senescence: A new insight in selected human diseases
Rajendran, P., Alzahrani, A. M., Hanieh, H., Kumar, S. A., Ammar, R. B., Rengarajan, T., & Alhoot, M. A. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28895 · Cited by 126
Cellular senescence, senescence-associated secretory phenotype, and chronic kidney disease
Wang, W.-J., Cai, G.-Y., & Chen, X.-M. (2017) · Oncotarget · doi:10.18632/oncotarget.17327 · Cited by 121
Senescent stroma promotes prostate cancer progression: The role of miR‐210
Taddei, M. L., Cavallini, L., Comito, G., Giannoni, E., Folini, M., Marini, A., Gandellini, P., Morandi, A., Pintus, G., Raspollini, M. R., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.07.009 · Cited by 122
Rey, M. J. D., Valín, Á., Usategui, A., Ergueta, S., Martín, E., Municio, C., Cañete, J. D. D., Blanco, F. J., Criado, G., & Pablos, J. L. (2019) · Immunity & Ageing · doi:10.1186/s12979-019-0169-4 · Cited by 120
Cellular senescence: Neither irreversible nor reversible
Reimann, M., Lee, S., & Schmitt, C. A. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20232136 · Cited by 125
Liu, X., Hoft, D. F., & Peng, G. (2020) · Journal of Clinical Investigation · doi:10.1172/jci133679 · Cited by 116
Peiris-Pagès, M., Sotgia, F., & Lisanti, M. P. (2015) · Oncotarget · doi:10.18632/oncotarget.3828 · Cited by 115
Senescent Cells and Their Secretory Phenotype as Targets for Cancer Therapy
Velarde, M. C., Demaria, M., & Campisi, J. (2013) · Interdisciplinary Topics in Gerontology and Geriatrics · doi:10.1159/000343572 · Cited by 112
Self-citationThe emerging role of senescent cells in tissue homeostasis and pathophysiology
Tominaga, K. (2015) · Pathobiology of Aging & Age-related Diseases · doi:10.3402/pba.v5.27743 · Cited by 117
Palbociclib: an evidence-based review of its potential in the treatment of breast cancer
Traina, T. A., Cadoo, K. A., & Gucalp, A. (2014) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s46725 · Cited by 112
Targeting senescence as an anticancer therapy
Bousset, L., & Gil, J. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13312 · Cited by 113
Circulating Tumor Cells: Fluid Surrogates of Solid Tumors
Thiele, J.-A., Bethel, K., Králíčková, M., & Kuhn, P. (2017) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-052016-100256 · Cited by 107
Senescent Fibroblasts Enhance Early Skin Carcinogenic Events via a Paracrine MMP-PAR-1 Axis
Malaquin, N., Vercamer, C., Bouali, F., Martien, S., Deruy, E., Wernert, N., Chwastyniak, M., Pinet, F., Abbadie, C., & Pourtier, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063607 · Cited by 110
Filippi‐Chiela, E. C., Silva, M. M. B. E., Thomé, M. P. M., & Lenz, G. (2015) · Autophagy · doi:10.1080/15548627.2015.1009795 · Cited by 97
Cellular senescence of renal tubular epithelial cells in acute kidney injury
Chen, J., Zhang, H., Yi, X., Dou, Q., Yang, X., Chen, J., Chen, J., & Chen, K. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-01831-9 · Cited by 103
Hubáčková, S., Kucerova, A., Michlits, G., Kyjacová, L., Reiniš, M., Korolov, O., Bártek, J., & Hodný, Z. (2015) · Oncogene · doi:10.1038/onc.2015.162 · Cited by 97
Cancer secretome and inflammation: The bright and the dark sides of NF-κB
Capece, D., Verzella, D., Tessitore, A., Alesse, E., Capalbo, C., & Zazzeroni, F. (2017) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2017.08.004 · Cited by 94
Shen, W., Liu, L., & Zeng, S. (2018) · Cancer translational medicine · doi:10.4103/ctm.ctm_22_18 · Cited by 92
Non-cell autonomous effects of the senescence-associated secretory phenotype in cancer therapy.
Saleh, T., Tyutynuk-Massey, L., Cudjoe, E. K., Idowu, M. O., Landry, J. W., & Gewirtz, D. A. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00164 · Cited by 85
Abulaiti, A., Shintani, Y., Funaki, S., Nakagiri, T., Inoue, M., Sawabata, N., Minami, M., & Okumura, M. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.08.008 · Cited by 86
HIV-associated cellular senescence: A contributor to accelerated aging
Cohen, J., & Torres, C. A. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.12.004 · Cited by 93
Exploiting tumor cell senescence in anticancer therapy
Lee, M., & Lee, J. (2014) · BMB Reports · doi:10.5483/bmbrep.2014.47.2.005 · Cited by 85
Miklikova, S., Matúšková, M., Boháč, M., Toro, L., Durinikova, E., Tyčiaková, S., Demková, L., Gurský, J., & Kučerová, L. (2016) · Cell Communication and Signaling · doi:10.1186/s12964-016-0127-0 · Cited by 82
Redox changes and cellular senescence in Alzheimer's disease
Yu, N., Pasha, M., & Chua, J. J. E. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103048 · Cited by 80
Selenium supplementation and oxidative stress: A review
Zakeri, N., Kelishadi, M. R., Asbaghi, O., Naeini, F., Afsharfar, M., Mirzadeh, E., & naserizadeh, S. K. (2021) · PharmaNutrition · doi:10.1016/j.phanu.2021.100263 · Cited by 78
Kyjacová, L., Hubáčková, S., Krejčíková, K., Strauss, R., Hanzlíková, H., Dzijak, R., Imrichová, T., Simova, J., Reiniš, M., Bártek, J., et al. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.97 · Cited by 73
TGF-β in the microenvironment induces a physiologically occurring immune-suppressive senescent state
Matsuda, S., Revandkar, A., Dubash, T. D., Ravi, A., Wittner, B. S., Lin, M., Morris, R. T., Burr, R., Guo, H., Seeger, K., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112129 · Cited by 76
Premature aging/senescence in cancer cells facing therapy: good or bad?
Calvo, L., Ghadaouia, S., Martinez, A., & Rodier, F. (2015) · Biogerontology · doi:10.1007/s10522-015-9593-9 · Cited by 74
The Role of Smoothened in Cancer
Jeng, K., Sheen, I., Leu, C., Tseng, P., & Chang, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186863 · Cited by 67
Kim, E., Rebecca, V. W., Smalley, I., Messina, J. L., Mathew, R. A., Maria–Engler, S. S., Basanta, D., Smalley, K. S. M., & Anderson, A. R. A. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1720 · Cited by 67
Liu, Y., Zhang, J., Sun, X., Su, Q., & You, C. (2017) · Oncotarget · doi:10.18632/oncotarget.17136 · Cited by 65
Wang, H., Yuan, S., Zheng, Q., Zhang, S., Zhang, Q., Ji, S., Wang, W. J., Cao, Y., Guo, Y., Yang, X., et al. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.01.025 · Cited by 67
The controversial role of senescence-associated secretory phenotype (SASP) in cancer therapy
Cao, L., Li, K., Li, Q., Tong, Q., Wang, Y., & Huang, L. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02475-8 · Cited by 79
cFLIP suppression and DR5 activation sensitize senescent cancer cells to senolysis
Wang, L., Jin, H., Jochems, F., Wang, S., Lieftink, C., Martinez, I. M., Conti, G. D., Edwards, F., de Oliveira, R. L., Schepers, A. G., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00462-2 · Cited by 68
Homeostatic Signaling by Cell–Cell Junctions and Its Dysregulation during Cancer Progression
Yu, Y., & Elble, R. C. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5020026 · Cited by 62
Liu, Y., Yu, C.-H., Wu, Y., Sun, X., Su, Q., You, C., & Xin, H. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13118 · Cited by 60
New Insights into the Role of Epithelial–Mesenchymal Transition during Aging
Santos, F. D. S., Moreira, C., Pereira, S. N., & de Jesus, B. B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040891 · Cited by 57
Senescence under appraisal: hopes and challenges revisited
Davan-Wetton, C. S. A., Pessolano, E., Perretti, M., & Montero‐Melendez, T. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03746-x · Cited by 61
Shintani, Y., Abulaiti, A., Kimura, T., Funaki, S., Nakagiri, T., Inoue, M., Sawabata, N., Minami, M., Morii, E., & Okumura, M. (2013) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2013.03.092 · Cited by 57
Targeting normal and cancer senescent cells as a strategy of senotherapy
Sikora, E., Bielak-Żmijewska, A., & Mosieniak, G. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100941 · Cited by 59
Alveolar type 2 epithelial cell senescence and radiation-induced pulmonary fibrosis
Zhou, S., Zhu, J., Zhou, P., & Gu, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.999600 · Cited by 58
Lipid Players of Cellular Senescence
Millner, A., & Atilla‐Gokcumen, G. E. (2020) · Metabolites · doi:10.3390/metabo10090339 · Cited by 60
Cirillo, N., Vicidomini, A., McCullough, M. J., Gambardella, A., Hassona, Y. M., Prime, S. S., & Colella, G. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24908 · Cited by 52
Cellular senescence involves an intracrine prostaglandin E2 pathway in human fibroblasts
Martien, S., Pluquet, O., Vercamer, C., Malaquin, N., Martin, N., Gosselin, K., Pourtier, A., & Abbadie, C. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.04.005 · Cited by 50
MicroRNA profiling reveals distinct profiles for tissue-derived and cultured endothelial cells
Kuosmanen, S. M., Kansanen, E., Sihvola, V., & Levonen, A.-L. (2017) · Scientific Reports · doi:10.1038/s41598-017-11487-4 · Cited by 48
Jin, J., Tao, J., Gu, X., Yu, Z., Wang, R., Zuo, G., Li, Q., Lv, X., & Miao, D. (2017) · Scientific Reports · doi:10.1038/s41598-017-06868-8 · Cited by 48
RetractedYang, M., Liu, P., Wang, K., Glorieux, C., Hu, Y., Wen, S., Jiang, W., & Huang, P. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12032 · Cited by 45
Autophagy and senescence: the molecular mechanisms and implications in liver diseases
Li, Q., Lin, Y., Liang, G., Xiao, N., Zhang, H., Yang, X., Yang, J., & Liu, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316880 · Cited by 43
Li, D., de Glas, N. A., & Hurria, A. (2015) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2015.08.003 · Cited by 44
Targeting senescence to delay progression of multiple sclerosis
Oost, W., Talma, N., Meilof, J. F., & Laman, J. D. (2018) · Journal of Molecular Medicine · doi:10.1007/s00109-018-1686-x · Cited by 47
Mechanisms of Hydroxyurea‐Induced Cellular Senescence: An Oxidative Stress Connection?
Kapor, S., Čokić, V. P., & Santibanez, J. F. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/7753857 · Cited by 46
Metadata
- Authors
- Laberge, R.-M., Awad, P., Campisi, J., & Desprez, P.-Y.
- Affiliations
- Buck Institute for Research on Aging (US)
- Corresponding author
- Desprez, Pierre-Yves
- Venue
- Cancer Microenvironment
- Published
- 2011-06-25
- Volume
- 5
- Issue
- 1
- Pages
- 39-44
- ISSN
- 1875-2284 (ISSN-L)
- 1875-2292
- PMC
- PMC3343197
- OpenAlex
- W2083594352
- Cited by
- 255
- References
- 65
- Citations by year
- 2026: 11 · 2025: 14 · 2024: 26 · 2023: 20 · 2022: 17 · 2021: 20 · 2020: 22 · 2019: 15 · 2018: 20 · 2017: 24 · 2016: 13 · 2015: 12 · 2014: 15 · 2013: 14 · 2012: 9
- FWCI
- 8.95
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cancer Microenvironment (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- epithelial-mesenchymal transition, cellular senescence, senescence-associated secretory phenotype, senescent fibroblasts, tumor progression, metastasis, tumor microenvironment, interleukins, tumor invasion
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
